202 related articles for article (PubMed ID: 29343281)
41. Chlamydophila pneumoniae induces expression of toll-like receptor 4 and release of TNF-alpha and MIP-2 via an NF-kappaB pathway in rat type II pneumocytes.
Wissel H; Schulz C; Koehne P; Richter E; Maass M; Rüdiger M
Respir Res; 2005 Jun; 6(1):51. PubMed ID: 15935092
[TBL] [Abstract][Full Text] [Related]
42. TLR4 activates NF-κB in human ovarian granulosa tumor cells.
Woods DC; White YA; Dau C; Johnson AL
Biochem Biophys Res Commun; 2011 Jun; 409(4):675-80. PubMed ID: 21616060
[TBL] [Abstract][Full Text] [Related]
43. C-reactive protein triggers inflammatory responses partly via TLR4/IRF3/NF-κB signaling pathway in rat vascular smooth muscle cells.
Liu N; Liu JT; Ji YY; Lu PP
Life Sci; 2010 Sep; 87(11-12):367-74. PubMed ID: 20670634
[TBL] [Abstract][Full Text] [Related]
44. Triggering of toll-like receptors 2 and 4 by Aspergillus fumigatus conidia in immortalized human corneal epithelial cells to induce inflammatory cytokines.
Zhao J; Wu XY
Chin Med J (Engl); 2008 Mar; 121(5):450-4. PubMed ID: 18364120
[TBL] [Abstract][Full Text] [Related]
45. Robinin modulates TLR/NF-κB signaling pathway in oxidized LDL induced human peripheral blood mononuclear cells.
Janeesh PA; Sasikala V; Dhanya CR; Abraham A
Int Immunopharmacol; 2014 Jan; 18(1):191-7. PubMed ID: 24295649
[TBL] [Abstract][Full Text] [Related]
46. Knockout of toll-like receptor-4 attenuates the pro-inflammatory state of diabetes.
Devaraj S; Tobias P; Jialal I
Cytokine; 2011 Sep; 55(3):441-5. PubMed ID: 21498084
[TBL] [Abstract][Full Text] [Related]
47. Pellino-3 promotes endotoxin tolerance and acts as a negative regulator of TLR2 and TLR4 signaling.
Murphy MB; Xiong Y; Pattabiraman G; Manavalan TT; Qiu F; Medvedev AE
J Leukoc Biol; 2015 Dec; 98(6):963-74. PubMed ID: 26310831
[TBL] [Abstract][Full Text] [Related]
48. Natural killer cell activity, lymphocyte proliferation, and cytokine profile in tumor-bearing mice treated with MAPA, a magnesium aggregated polymer from Aspergillus oryzae.
Justo GZ; Durán N; Queiroz ML
Immunopharmacol Immunotoxicol; 2003 Aug; 25(3):305-19. PubMed ID: 19180795
[TBL] [Abstract][Full Text] [Related]
49. Glucocorticoid receptor activation inhibits chemotherapy-induced cell death in high-grade serous ovarian carcinoma.
Stringer-Reasor EM; Baker GM; Skor MN; Kocherginsky M; Lengyel E; Fleming GF; Conzen SD
Gynecol Oncol; 2015 Sep; 138(3):656-62. PubMed ID: 26115975
[TBL] [Abstract][Full Text] [Related]
50. Knockdown of BRCA2 enhances cisplatin and cisplatin-induced autophagy in ovarian cancer cells.
Wan B; Dai L; Wang L; Zhang Y; Huang H; Qian G; Yu T
Endocr Relat Cancer; 2018 Jan; 25(1):69-82. PubMed ID: 29066501
[TBL] [Abstract][Full Text] [Related]
51. Expression and function of Toll-like receptors in peripheral blood mononuclear cells from patients with ovarian cancer.
Zhang X; Xu J; Ke X; Zhang S; Huang P; Xu T; Huang L; Lou J; Shi X; Sun R; Wang F; Pan S
Cancer Immunol Immunother; 2015 Mar; 64(3):275-86. PubMed ID: 25376541
[TBL] [Abstract][Full Text] [Related]
52. A Strong B-cell Response Is Part of the Immune Landscape in Human High-Grade Serous Ovarian Metastases.
Montfort A; Pearce O; Maniati E; Vincent BG; Bixby L; Böhm S; Dowe T; Wilkes EH; Chakravarty P; Thompson R; Topping J; Cutillas PR; Lockley M; Serody JS; Capasso M; Balkwill FR
Clin Cancer Res; 2017 Jan; 23(1):250-262. PubMed ID: 27354470
[TBL] [Abstract][Full Text] [Related]
53. Role of Toll-like receptor 2 and 4 signaling pathways on the inflammatory response to resistance training in elderly subjects.
Rodriguez-Miguelez P; Fernandez-Gonzalo R; Almar M; Mejías Y; Rivas A; de Paz JA; Cuevas MJ; González-Gallego J
Age (Dordr); 2014; 36(6):9734. PubMed ID: 25427999
[TBL] [Abstract][Full Text] [Related]
54. ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy.
Saglam O; Xiong Y; Marchion DC; Strosberg C; Wenham RM; Johnson JJ; Saeed-Vafa D; Cubitt C; Hakam A; Magliocco AM
Cancer Control; 2017 Jan; 24(1):89-95. PubMed ID: 28178720
[TBL] [Abstract][Full Text] [Related]
55. Phyllanthusmin Derivatives Induce Apoptosis and Reduce Tumor Burden in High-Grade Serous Ovarian Cancer by Late-Stage Autophagy Inhibition.
Young AN; Herrera D; Huntsman AC; Korkmaz MA; Lantvit DD; Mazumder S; Kolli S; Coss CC; King S; Wang H; Swanson SM; Kinghorn AD; Zhang X; Phelps MA; Aldrich LN; Fuchs JR; Burdette JE
Mol Cancer Ther; 2018 Oct; 17(10):2123-2135. PubMed ID: 30018048
[TBL] [Abstract][Full Text] [Related]
56. Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer.
Létourneau IJ; Quinn MC; Wang LL; Portelance L; Caceres KY; Cyr L; Delvoye N; Meunier L; de Ladurantaye M; Shen Z; Arcand SL; Tonin PN; Provencher DM; Mes-Masson AM
BMC Cancer; 2012 Aug; 12():379. PubMed ID: 22931248
[TBL] [Abstract][Full Text] [Related]
57. Cisplatin-based polychemotherapy reduces the natural cytotoxicity of peripheral blood mononuclear cells in patients with advanced ovarian carcinoma and their in vitro responsiveness to interleukin-12 incubation.
Garzetti GG; Ciavattini A; Muzzioli M; Romanini C
Cancer; 1999 May; 85(10):2226-31. PubMed ID: 10326702
[TBL] [Abstract][Full Text] [Related]
58. Toll-like receptor expression in normal ovary and ovarian tumors.
Zhou M; McFarland-Mancini MM; Funk HM; Husseinzadeh N; Mounajjed T; Drew AF
Cancer Immunol Immunother; 2009 Sep; 58(9):1375-85. PubMed ID: 19184006
[TBL] [Abstract][Full Text] [Related]
59. Regulation of UT-OC-3 ovarian carcinoma cells by cytokines: inhibitory effects on cell proliferation and activation of transcription factors AP-1 and NF-kappaB.
Seppänen M; Lin L; Punnonen J; Grénman S; Punnonen R; Vihko KK
Eur J Endocrinol; 2000 Apr; 142(4):393-401. PubMed ID: 10754482
[TBL] [Abstract][Full Text] [Related]
60. Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden.
Stone ML; Chiappinelli KB; Li H; Murphy LM; Travers ME; Topper MJ; Mathios D; Lim M; Shih IM; Wang TL; Hung CF; Bhargava V; Wiehagen KR; Cowley GS; Bachman KE; Strick R; Strissel PL; Baylin SB; Zahnow CA
Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10981-E10990. PubMed ID: 29203668
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
